Global Cardiology Surgery, Devices and Drugs Market Research and Analysis, 2014-2020
MARKET INSIGHTS
Global cardiology surgery, devices and drugs market is expected to grow at a CAGR of 7% for the forecasted period of 2015-2020. The report covers three major segments of cardiology surgery, devices and drugs market which includes surgeries, devices and drugs. Cardiovascular diseases are the number one cause of death globally. CVDs are responsible for over 3 million diseases annually. Some of the major CVDs include coronary heart diseases, stroke, hypertensive heart diseases, inflammatory heart diseases, rheumatoid heart diseases and others. Coronary heart diseases are the leading cause of death followed by strokes. The prevalence and incidence rate of heart diseases are on a rise; especially in major emerging countries such as India, China and Japan. The market of cardiology surgery, devices and drugs are also on a rise.
One of the major factors driving the market is medical tourism. Especially in emerging markets such as India, ASEAN countries and China, the cost of surgery and treatment for cardiovascular diseases is low. In India a heart surgery costs around 1,500 whereas in the United States it costs 5 to 10 times more than India. Hence, many Americans prefer to travel to India for their treatment.
North America is the leading market with highest market share. The market is expected to grow at a CAGR of 7 percent. North American marker is followed by Europe, Asia Pacific and Rest of the world. Asia Pacific market is expected to have highest CAGR of 9.3% for the forecasted period of 2015-2020.
Global cardiology surgery, devices and drugs market is expected to grow at a CAGR of 7% for the forecasted period of 2015-2020. The report covers three major segments of cardiology surgery, devices and drugs market which includes surgeries, devices and drugs. Cardiovascular diseases are the number one cause of death globally. CVDs are responsible for over 3 million diseases annually. Some of the major CVDs include coronary heart diseases, stroke, hypertensive heart diseases, inflammatory heart diseases, rheumatoid heart diseases and others. Coronary heart diseases are the leading cause of death followed by strokes. The prevalence and incidence rate of heart diseases are on a rise; especially in major emerging countries such as India, China and Japan. The market of cardiology surgery, devices and drugs are also on a rise.
One of the major factors driving the market is medical tourism. Especially in emerging markets such as India, ASEAN countries and China, the cost of surgery and treatment for cardiovascular diseases is low. In India a heart surgery costs around 1,500 whereas in the United States it costs 5 to 10 times more than India. Hence, many Americans prefer to travel to India for their treatment.
North America is the leading market with highest market share. The market is expected to grow at a CAGR of 7 percent. North American marker is followed by Europe, Asia Pacific and Rest of the world. Asia Pacific market is expected to have highest CAGR of 9.3% for the forecasted period of 2015-2020.
REPORT SUMMARY
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
1.2.4. EXCEPTIONS
MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. GAP ANALYSIS
2.3. HISTORICAL ANALYSIS
2.4. CURRENT MARKET TRENDS
2.5. ANALYST INSIGHT
2.5.1. KEY FINDINGS
2.5.2. RECOMMENDATION
2.5.3. CONCLUSION
2.6. REGULATION
2.6.1. TAX LAWS
2.6.1.1. UNITED STATES
2.6.1.2. EUROPEAN UNION
2.6.1.3. CHINA
2.6.1.4. INDIA
2.6.1.5. REST OF THE WORLD
2.6.2. DRUGS AND DEVICE REGULATIONS
2.6.2.1. UNITED STATES
2.6.2.2. EUROPEAN UNION
2.6.2.3. CHINA
2.6.2.4. INDIA
2.6.2.5. REST OF THE WORLD
2.7. TYPE OF CARDIOVASCULAR DISEASES
2.7.1. CORONARY HEART DISEASES
2.7.2. STROKE
2.7.3. HYPERTENSIVE HEART DISEASES
2.7.4. INFLAMMATORY HEART DISEASES
2.7.5. RHEUMATIC HEART DISEASES
2.7.6. OTHER HEART DISEASES
MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. INCREASING INCIDENCE AND PREVALENCE OF CARDIOVASCULAR DISEASES
3.1.2. MEDICAL TOURISM IN EMERGING MARKET
3.1.3. INNOVATIONS AND DEVELOPMENT OF NEW PRODUCTS
3.1.4. AVAILABILITY OF REMOTE MONITORING SOLUTIONS
3.1.5. RISING HEALTHCARE EXPENDITURE
3.2. RESTRAINT
3.2.1. HIGH COST OF SURGERIES AND MEDICAL DEVICES IN BOTH DEVELOPED AND EMERGING MARKETS
3.2.2. STRICT GOVERNMENT POLICIES
3.3. OPPORTUNITY
3.3.1. EMERGING MARKETS
3.3.2. GROWING HYBRID OPERATING ROOMS MARKET
PARENT MARKET ANALYSIS
MARKET SEGMENTATION
5.1. GLOBAL CARDIOLOGY DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1. GLOBAL ANGIOPLASTY MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.2. GLOBAL CARDIOVASCULAR STENTS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.3. GLOBAL CARDIOVASCULAR CATHETERS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.4. GLOBAL CARDIAC RHYTHM MANAGEMENT MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.5. GLOBAL CARDIOVASCULAR ASSISTIVE DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.6. GLOBAL OTHER CARDIOLOGY DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
5.2. GLOBAL CARDIOLOGY DRUGS MARKET BY INDICATIONS 2014-2020
5.2.1. GLOBAL ANTITHROMBOTIC DRUGS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.2.2. GLOBAL ANTIDYSLIPIDEMIC DRUGS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.2.3. GLOBAL ANTIHYPERTENSIVE DRUGS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.2.4. GLOBAL ANTI STROKE DRUGS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.3. GLOBAL CARDIOLOGY DRUGS MARKET BY MECHANISM OF ACTION 2014-2020
5.3.1. GLOBAL BETA BLOCKERS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.3.2. GLOBAL BETA AGONISTS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.3.3. GLOBAL ALPHA BLOCKERS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.3.4. GLOBAL ALPHA AGONISTS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.3.5. GLOBAL SODIUM CHANNEL BLOCKERS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.3.6. GLOBAL CALCIUM CHANNEL BLOCKERS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.3.7. GLOBAL VASODILATORS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.3.8. GLOBAL RENIN INHIBITORS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.3.9. GLOBAL ANGIOTENSIN RECEPTOR BLOCKERS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.3.10. GLOBAL DIURETICS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.3.11. GLOBAL THROMBOLYTICS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.4. GLOBAL CARDIOLOGY SURGERIES MARKET RESEARCH AND ANALYSIS, 2014-2020
5.4.1. GLOBAL CORONARY ARTERY BYPASS GRAFTING MARKET RESEARCH AND ANALYSIS, 2014-2020
5.4.2. GLOBAL TRANSMYOCARDIAL LASER REVASCULARIZATION MARKET RESEARCH AND ANALYSIS, 2014-2020
5.4.3. GLOBAL HEART VALVE REPAIR MARKET RESEARCH AND ANALYSIS, 2014-2020
5.4.4. GLOBAL ARRHYTHMIA TREATMENT MARKET RESEARCH AND ANALYSIS, 2014-2020
5.4.5. GLOBAL ANEURYSM REPAIR MARKET RESEARCH AND ANALYSIS, 2014-2020
5.4.6. GLOBAL HEART TRANSPLANT MARKET RESEARCH AND ANALYSIS, 2014-2020
COMPETITIVE LANDSCAPE
6.1. MARKET SHARE ANALYSIS
6.2. KEY COMPANY ANALYSIS
REGIONAL ANALYSIS
7.1. NORTH AMERICAN MARKET RESEARCH AND ANALYSIS, 2014-2020
7.1.1. UNITED STATES MARKET RESEARCH AND ANALYSIS, 2014-2020
7.1.2. CANADA MARKET RESEARCH AND ANALYSIS, 2014-2020
7.2. EUROPEAN MARKET RESEARCH AND ANALYSIS, 2014-2020
7.2.1. WESTERN EUROPE MARKET RESEARCH AND ANALYSIS, 2014-2020
7.2.2. ROE MARKET RESEARCH AND ANALYSIS, 2014-2020
7.3. ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2014-2020
7.3.1. INDIA MARKET RESEARCH AND ANALYSIS, 2014-2020
7.3.2. CHINA MARKET RESEARCH AND ANALYSIS, 2014-2020
7.3.3. JAPAN MARKET RESEARCH AND ANALYSIS, 2014-2020
7.3.4. ROAPAC MARKET RESEARCH AND ANALYSIS, 2014-2020
7.4. REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2014-2020
COMPANY PROFILES
8.1. PFIZER
8.1.1. INTRODUCTION
8.1.2. PRODUCT PORTFOLIO
8.1.3. RECENT ACTIVITIES
8.1.4. SWOT
8.2. SANOFI S.A.
8.2.1. INTRODUCTION
8.2.2. PRODUCT PORTFOLIO
8.2.3. RECENT ACTIVITIES
8.2.4. SWOT
8.3. ASTRAZENECA
8.3.1. INTRODUCTION
8.3.2. PRODUCT PORTFOLIO
8.3.3. RECENT ACTIVITIES
8.3.4. SWOT
8.4. NOVARTIS
8.4.1. INTRODUCTION
8.4.2. PRODUCT PORTFOLIO
8.4.3. RECENT ACTIVITIES
8.4.4. SWOT
8.5. BRISTOL-MYERS SQUIBB
8.5.1. INTRODUCTION
8.5.2. PRODUCT PORTFOLIO
8.5.3. RECENT ACTIVITIES
8.5.4. SWOT
8.6. MERCK
8.6.1. INTRODUCTION
8.6.2. PRODUCT PORTFOLIO
8.6.3. RECENT ACTIVITIES
8.6.4. SWOT
8.7. BOSTON SCIENTIFIC CORPORATION
8.7.1. INTRODUCTION
8.7.2. PRODUCT PORTFOLIO
8.7.3. RECENT ACTIVITIES
8.7.4. SWOT
8.8. MEDTRONIC
8.8.1. INTRODUCTION
8.8.2. PRODUCT PORTFOLIO
8.8.3. RECENT ACTIVITIES
8.8.4. SWOT
8.9. ST. JUDE MEDICAL
8.9.1. INTRODUCTION
8.9.2. PRODUCT PORTFOLIO
8.9.3. RECENT ACTIVITIES
8.9.4. SWOT
8.10. COOK MEDICAL
8.10.1. INTRODUCTION
8.10.2. PRODUCT PORTFOLIO
8.10.3. RECENT ACTIVITIES
8.10.4. SWOT
8.11. CR BARD INC.
8.11.1. INTRODUCTION
8.11.2. PRODUCT PORTFOLIO
8.11.3. RECENT ACTIVITIES
8.11.4. SWOT
8.12. SUN PHARMA
8.12.1. INTRODUCTION
8.12.2. PRODUCT PORTFOLIO
8.12.3. RECENT ACTIVITIES
8.12.4. SWOT
8.13. GE HEALTHCARE
8.13.1. INTRODUCTION
8.13.2. PRODUCT PORTFOLIO
8.13.3. RECENT ACTIVITIES
8.13.4. SWOT
8.14. JOHNSON AND JOHNSON
8.14.1. INTRODUCTION
8.14.2. PRODUCT PORTFOLIO
8.14.3. RECENT ACTIVITIES
8.14.4. SWOT
8.15. TAKEDA PHARMACEUTICAL COMPANY LTD
8.15.1. INTRODUCTION
8.15.2. PRODUCT PORTFOLIO
8.15.3. RECENT ACTIVITIES
8.15.4. SWOT
8.16. DAIICHI SANKYO CO. LTD.
8.16.1. INTRODUCTION
8.16.2. PRODUCT PORTFOLIO
8.16.3. RECENT ACTIVITIES
8.16.4. SWOT
8.17. F. HOFFMANN-LA ROCHE LTD
8.17.1. INTRODUCTION
8.17.2. PRODUCT PORTFOLIO
8.17.3. RECENT ACTIVITIES
8.17.4. SWOT
8.18. BAYER AG
8.18.1. INTRODUCTION
8.18.2. PRODUCT PORTFOLIO
8.18.3. RECENT ACTIVITIES
8.18.4. SWOT
8.19. BOEHRINGER INGELHEIM
8.19.1. INTRODUCTION
8.19.2. PRODUCT PORTFOLIO
8.19.3. RECENT ACTIVITIES
8.19.4. SWOT
8.20. OTSUKA
8.20.1. INTRODUCTION
8.20.2. PRODUCT PORTFOLIO
8.20.3. RECENT ACTIVITIES
8.20.4. SWOT
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
1.2.4. EXCEPTIONS
MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. GAP ANALYSIS
2.3. HISTORICAL ANALYSIS
2.4. CURRENT MARKET TRENDS
2.5. ANALYST INSIGHT
2.5.1. KEY FINDINGS
2.5.2. RECOMMENDATION
2.5.3. CONCLUSION
2.6. REGULATION
2.6.1. TAX LAWS
2.6.1.1. UNITED STATES
2.6.1.2. EUROPEAN UNION
2.6.1.3. CHINA
2.6.1.4. INDIA
2.6.1.5. REST OF THE WORLD
2.6.2. DRUGS AND DEVICE REGULATIONS
2.6.2.1. UNITED STATES
2.6.2.2. EUROPEAN UNION
2.6.2.3. CHINA
2.6.2.4. INDIA
2.6.2.5. REST OF THE WORLD
2.7. TYPE OF CARDIOVASCULAR DISEASES
2.7.1. CORONARY HEART DISEASES
2.7.2. STROKE
2.7.3. HYPERTENSIVE HEART DISEASES
2.7.4. INFLAMMATORY HEART DISEASES
2.7.5. RHEUMATIC HEART DISEASES
2.7.6. OTHER HEART DISEASES
MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. INCREASING INCIDENCE AND PREVALENCE OF CARDIOVASCULAR DISEASES
3.1.2. MEDICAL TOURISM IN EMERGING MARKET
3.1.3. INNOVATIONS AND DEVELOPMENT OF NEW PRODUCTS
3.1.4. AVAILABILITY OF REMOTE MONITORING SOLUTIONS
3.1.5. RISING HEALTHCARE EXPENDITURE
3.2. RESTRAINT
3.2.1. HIGH COST OF SURGERIES AND MEDICAL DEVICES IN BOTH DEVELOPED AND EMERGING MARKETS
3.2.2. STRICT GOVERNMENT POLICIES
3.3. OPPORTUNITY
3.3.1. EMERGING MARKETS
3.3.2. GROWING HYBRID OPERATING ROOMS MARKET
PARENT MARKET ANALYSIS
MARKET SEGMENTATION
5.1. GLOBAL CARDIOLOGY DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.1. GLOBAL ANGIOPLASTY MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.2. GLOBAL CARDIOVASCULAR STENTS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.3. GLOBAL CARDIOVASCULAR CATHETERS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.4. GLOBAL CARDIAC RHYTHM MANAGEMENT MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.5. GLOBAL CARDIOVASCULAR ASSISTIVE DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
5.1.6. GLOBAL OTHER CARDIOLOGY DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
5.2. GLOBAL CARDIOLOGY DRUGS MARKET BY INDICATIONS 2014-2020
5.2.1. GLOBAL ANTITHROMBOTIC DRUGS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.2.2. GLOBAL ANTIDYSLIPIDEMIC DRUGS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.2.3. GLOBAL ANTIHYPERTENSIVE DRUGS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.2.4. GLOBAL ANTI STROKE DRUGS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.3. GLOBAL CARDIOLOGY DRUGS MARKET BY MECHANISM OF ACTION 2014-2020
5.3.1. GLOBAL BETA BLOCKERS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.3.2. GLOBAL BETA AGONISTS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.3.3. GLOBAL ALPHA BLOCKERS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.3.4. GLOBAL ALPHA AGONISTS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.3.5. GLOBAL SODIUM CHANNEL BLOCKERS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.3.6. GLOBAL CALCIUM CHANNEL BLOCKERS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.3.7. GLOBAL VASODILATORS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.3.8. GLOBAL RENIN INHIBITORS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.3.9. GLOBAL ANGIOTENSIN RECEPTOR BLOCKERS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.3.10. GLOBAL DIURETICS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.3.11. GLOBAL THROMBOLYTICS MARKET RESEARCH AND ANALYSIS, 2014-2020
5.4. GLOBAL CARDIOLOGY SURGERIES MARKET RESEARCH AND ANALYSIS, 2014-2020
5.4.1. GLOBAL CORONARY ARTERY BYPASS GRAFTING MARKET RESEARCH AND ANALYSIS, 2014-2020
5.4.2. GLOBAL TRANSMYOCARDIAL LASER REVASCULARIZATION MARKET RESEARCH AND ANALYSIS, 2014-2020
5.4.3. GLOBAL HEART VALVE REPAIR MARKET RESEARCH AND ANALYSIS, 2014-2020
5.4.4. GLOBAL ARRHYTHMIA TREATMENT MARKET RESEARCH AND ANALYSIS, 2014-2020
5.4.5. GLOBAL ANEURYSM REPAIR MARKET RESEARCH AND ANALYSIS, 2014-2020
5.4.6. GLOBAL HEART TRANSPLANT MARKET RESEARCH AND ANALYSIS, 2014-2020
COMPETITIVE LANDSCAPE
6.1. MARKET SHARE ANALYSIS
6.2. KEY COMPANY ANALYSIS
REGIONAL ANALYSIS
7.1. NORTH AMERICAN MARKET RESEARCH AND ANALYSIS, 2014-2020
7.1.1. UNITED STATES MARKET RESEARCH AND ANALYSIS, 2014-2020
7.1.2. CANADA MARKET RESEARCH AND ANALYSIS, 2014-2020
7.2. EUROPEAN MARKET RESEARCH AND ANALYSIS, 2014-2020
7.2.1. WESTERN EUROPE MARKET RESEARCH AND ANALYSIS, 2014-2020
7.2.2. ROE MARKET RESEARCH AND ANALYSIS, 2014-2020
7.3. ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2014-2020
7.3.1. INDIA MARKET RESEARCH AND ANALYSIS, 2014-2020
7.3.2. CHINA MARKET RESEARCH AND ANALYSIS, 2014-2020
7.3.3. JAPAN MARKET RESEARCH AND ANALYSIS, 2014-2020
7.3.4. ROAPAC MARKET RESEARCH AND ANALYSIS, 2014-2020
7.4. REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2014-2020
COMPANY PROFILES
8.1. PFIZER
8.1.1. INTRODUCTION
8.1.2. PRODUCT PORTFOLIO
8.1.3. RECENT ACTIVITIES
8.1.4. SWOT
8.2. SANOFI S.A.
8.2.1. INTRODUCTION
8.2.2. PRODUCT PORTFOLIO
8.2.3. RECENT ACTIVITIES
8.2.4. SWOT
8.3. ASTRAZENECA
8.3.1. INTRODUCTION
8.3.2. PRODUCT PORTFOLIO
8.3.3. RECENT ACTIVITIES
8.3.4. SWOT
8.4. NOVARTIS
8.4.1. INTRODUCTION
8.4.2. PRODUCT PORTFOLIO
8.4.3. RECENT ACTIVITIES
8.4.4. SWOT
8.5. BRISTOL-MYERS SQUIBB
8.5.1. INTRODUCTION
8.5.2. PRODUCT PORTFOLIO
8.5.3. RECENT ACTIVITIES
8.5.4. SWOT
8.6. MERCK
8.6.1. INTRODUCTION
8.6.2. PRODUCT PORTFOLIO
8.6.3. RECENT ACTIVITIES
8.6.4. SWOT
8.7. BOSTON SCIENTIFIC CORPORATION
8.7.1. INTRODUCTION
8.7.2. PRODUCT PORTFOLIO
8.7.3. RECENT ACTIVITIES
8.7.4. SWOT
8.8. MEDTRONIC
8.8.1. INTRODUCTION
8.8.2. PRODUCT PORTFOLIO
8.8.3. RECENT ACTIVITIES
8.8.4. SWOT
8.9. ST. JUDE MEDICAL
8.9.1. INTRODUCTION
8.9.2. PRODUCT PORTFOLIO
8.9.3. RECENT ACTIVITIES
8.9.4. SWOT
8.10. COOK MEDICAL
8.10.1. INTRODUCTION
8.10.2. PRODUCT PORTFOLIO
8.10.3. RECENT ACTIVITIES
8.10.4. SWOT
8.11. CR BARD INC.
8.11.1. INTRODUCTION
8.11.2. PRODUCT PORTFOLIO
8.11.3. RECENT ACTIVITIES
8.11.4. SWOT
8.12. SUN PHARMA
8.12.1. INTRODUCTION
8.12.2. PRODUCT PORTFOLIO
8.12.3. RECENT ACTIVITIES
8.12.4. SWOT
8.13. GE HEALTHCARE
8.13.1. INTRODUCTION
8.13.2. PRODUCT PORTFOLIO
8.13.3. RECENT ACTIVITIES
8.13.4. SWOT
8.14. JOHNSON AND JOHNSON
8.14.1. INTRODUCTION
8.14.2. PRODUCT PORTFOLIO
8.14.3. RECENT ACTIVITIES
8.14.4. SWOT
8.15. TAKEDA PHARMACEUTICAL COMPANY LTD
8.15.1. INTRODUCTION
8.15.2. PRODUCT PORTFOLIO
8.15.3. RECENT ACTIVITIES
8.15.4. SWOT
8.16. DAIICHI SANKYO CO. LTD.
8.16.1. INTRODUCTION
8.16.2. PRODUCT PORTFOLIO
8.16.3. RECENT ACTIVITIES
8.16.4. SWOT
8.17. F. HOFFMANN-LA ROCHE LTD
8.17.1. INTRODUCTION
8.17.2. PRODUCT PORTFOLIO
8.17.3. RECENT ACTIVITIES
8.17.4. SWOT
8.18. BAYER AG
8.18.1. INTRODUCTION
8.18.2. PRODUCT PORTFOLIO
8.18.3. RECENT ACTIVITIES
8.18.4. SWOT
8.19. BOEHRINGER INGELHEIM
8.19.1. INTRODUCTION
8.19.2. PRODUCT PORTFOLIO
8.19.3. RECENT ACTIVITIES
8.19.4. SWOT
8.20. OTSUKA
8.20.1. INTRODUCTION
8.20.2. PRODUCT PORTFOLIO
8.20.3. RECENT ACTIVITIES
8.20.4. SWOT
LIST OF TABLES
TABLE # 1 GLOBAL CARDIOLOGY DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 2 GLOBAL ANGIOPLASTY MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 3 GLOBAL CARDIOVASCULAR STENTS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 4 GLOBAL CARDIOVASCULAR CATHETERS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 5 GLOBAL CARDIAC RHYTHM MANAGEMENT MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 6 GLOBAL CARDIOVASCULAR ASSISTIVE DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 7 GLOBAL OTHER CARDIOLOGY DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 8 GLOBAL CARDIOLOGY DRUGS MARKET BY INDICATIONS 2014-2020
TABLE # 9 GLOBAL ANTITHROMBOTIC DRUGS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 10 GLOBAL ANTIDYSLIPIDEMIC DRUGS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 11 GLOBAL ANTIHYPERTENSIVE DRUGS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 12 GLOBAL ANTI STROKE DRUGS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 13 GLOBAL CARDIOLOGY DRUGS MARKET BY MECHANISM OF ACTION 2014-2020
TABLE # 14 GLOBAL BETA BLOCKERS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 15 GLOBAL BETA AGONISTS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 16 GLOBAL ALPHA BLOCKERS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 17 GLOBAL ALPHA AGONISTS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 18 GLOBAL SODIUM CHANNEL BLOCKERS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 19 GLOBAL CALCIUM CHANNEL BLOCKERS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 20 GLOBAL VASODILATORS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 21 GLOBAL RENIN INHIBITORS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 22 GLOBAL ANGIOTENSIN RECEPTOR BLOCKERS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 23 GLOBAL DIURETICS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 24 GLOBAL THROMBOLYTICS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 25 GLOBAL CARDIOLOGY SURGERIES MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 26 CORONARY ARTERY BYPASS GRAFTING MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 27 TRANSMYOCARDIAL LASER REVASCULARIZATION MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 28 HEART VALVE REPAIR MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 29 ARRHYTHMIA TREATMENT MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 30 ANEURYSM REPAIR MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 31 HEART TRANSPLANT MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 1 GLOBAL CARDIOLOGY DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 2 GLOBAL ANGIOPLASTY MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 3 GLOBAL CARDIOVASCULAR STENTS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 4 GLOBAL CARDIOVASCULAR CATHETERS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 5 GLOBAL CARDIAC RHYTHM MANAGEMENT MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 6 GLOBAL CARDIOVASCULAR ASSISTIVE DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 7 GLOBAL OTHER CARDIOLOGY DEVICES MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 8 GLOBAL CARDIOLOGY DRUGS MARKET BY INDICATIONS 2014-2020
TABLE # 9 GLOBAL ANTITHROMBOTIC DRUGS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 10 GLOBAL ANTIDYSLIPIDEMIC DRUGS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 11 GLOBAL ANTIHYPERTENSIVE DRUGS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 12 GLOBAL ANTI STROKE DRUGS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 13 GLOBAL CARDIOLOGY DRUGS MARKET BY MECHANISM OF ACTION 2014-2020
TABLE # 14 GLOBAL BETA BLOCKERS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 15 GLOBAL BETA AGONISTS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 16 GLOBAL ALPHA BLOCKERS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 17 GLOBAL ALPHA AGONISTS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 18 GLOBAL SODIUM CHANNEL BLOCKERS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 19 GLOBAL CALCIUM CHANNEL BLOCKERS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 20 GLOBAL VASODILATORS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 21 GLOBAL RENIN INHIBITORS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 22 GLOBAL ANGIOTENSIN RECEPTOR BLOCKERS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 23 GLOBAL DIURETICS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 24 GLOBAL THROMBOLYTICS MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 25 GLOBAL CARDIOLOGY SURGERIES MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 26 CORONARY ARTERY BYPASS GRAFTING MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 27 TRANSMYOCARDIAL LASER REVASCULARIZATION MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 28 HEART VALVE REPAIR MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 29 ARRHYTHMIA TREATMENT MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 30 ANEURYSM REPAIR MARKET RESEARCH AND ANALYSIS, 2014-2020
TABLE # 31 HEART TRANSPLANT MARKET RESEARCH AND ANALYSIS, 2014-2020
LIST OF FIGURES
FIGURE # 1 NORTH AMERICAN MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 2 UNITED STATES MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 3 CANADA MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 4 EUROPEAN MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 5 WESTERN EUROPE MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 6 ROE MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 7 ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 8 INDIA MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 9 CHINA MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 10 JAPAN MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 11 ROAPAC MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 12 REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2014-2020
COMPANIES MENTIONED
1. PFIZER
2. SANOFI S.A.
3. ASTRAZENECA
4. NOVARTIS
5. BRISTOL-MYERS SQUIBB
6. MERCK
7. BOSTON SCIENTIFIC CORPORATION
8. MEDTRONIC
9. ST. JUDE MEDICAL
10. COOK MEDICAL
11. CR BARD INC.
12. SUN PHARMA
13. GE HEALTHCARE
14. JOHNSON AND JOHNSON
15. TAKEDA PHARMACEUTICAL COMPANY LTD
16. DAIICHI SANKYO CO. LTD.
17. F. HOFFMANN-LA ROCHE LTD
18. BAYER AG
19. BOEHRINGER INGELHEIM
20. OTSUKA
FIGURE # 1 NORTH AMERICAN MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 2 UNITED STATES MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 3 CANADA MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 4 EUROPEAN MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 5 WESTERN EUROPE MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 6 ROE MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 7 ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 8 INDIA MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 9 CHINA MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 10 JAPAN MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 11 ROAPAC MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 12 REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2014-2020
COMPANIES MENTIONED
1. PFIZER
2. SANOFI S.A.
3. ASTRAZENECA
4. NOVARTIS
5. BRISTOL-MYERS SQUIBB
6. MERCK
7. BOSTON SCIENTIFIC CORPORATION
8. MEDTRONIC
9. ST. JUDE MEDICAL
10. COOK MEDICAL
11. CR BARD INC.
12. SUN PHARMA
13. GE HEALTHCARE
14. JOHNSON AND JOHNSON
15. TAKEDA PHARMACEUTICAL COMPANY LTD
16. DAIICHI SANKYO CO. LTD.
17. F. HOFFMANN-LA ROCHE LTD
18. BAYER AG
19. BOEHRINGER INGELHEIM
20. OTSUKA
